RecruitingPhase 3NCT04217512

Pantoprazole in Cisplatin Nephrotoxicity

Possible Protective Effect of Pantoprazole in Cisplatin Induced Nephrotoxicity in Patients With Head and Neck Cancer


Sponsor

Sherief Abd-Elsalam

Enrollment

60 participants

Start Date

May 1, 2019

Study Type

INTERVENTIONAL

Conditions

Summary

Pantoprazole in Cisplatin Nephrotoxicity


Eligibility

Plain Language Summary

Simplified for easier understanding

This study is testing whether pantoprazole (a common over-the-counter stomach acid medication) can protect the kidneys from damage caused by cisplatin, a strong chemotherapy drug frequently used to treat head and neck cancers. Cisplatin is effective but can cause kidney injury as a side effect, and researchers want to see if this simple, widely available medication can reduce that risk. **You may be eligible if...** - You have been diagnosed with head and neck cancer - You are scheduled to receive cisplatin chemotherapy as part of your treatment **You may NOT be eligible if...** - Your kidney function is already significantly reduced (GFR below 59 mL/min) - You have diabetes - Your liver enzymes are elevated more than 3 times above the normal upper limit Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGPantoprazole low dose

Pantoprazole 0.6 mg/kg

DRUGPantoprazole high dose

Pantoprazole 1.6 mg\\kg

OTHERStandard hydration

Standard hydration alone

DRUGCisplatin

Cisplatin


Locations(1)

Sherief Abd-Elsalam

Tanta, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04217512


Related Trials